
Brello Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: women pairing compounded GLP-1 with NAD+ or sermorelin bundles and included virtual fitness classes
Brello Health scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Brello Health's site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Brello Health is a women-focused telehealth platform offering compounded semaglutide and tirzepatide, with every plan including virtual fitness and nutrition classes, a private community, and the Brello app. Plans carry a 3-month minimum and renew automatically: semaglutide is $399 and tirzepatide $499 every 11 weeks, and a 6-month tirzepatide plan is $894.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
What is Brello Health?
Brello Health is an online wellness service focused on women that offers compounded tirzepatide and semaglutide, along with longevity treatments such as NAD+ and sermorelin. Every plan includes a provider health review, injection supplies, the Brello app, virtual fitness and nutrition classes, and a private member community. It suits people who want built-in community and coaching extras and are fine with a 3-month minimum commitment.
Vetted alternatives to Brello Health
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Brello Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $158/mo (3-month plan rate)
- What's included
- Medication · Consult
- Availability
- 34 states + DC
- FDA status
- No FDA warning letter on record
How we scored Brello Health
Each dimension is scored algorithmically from Brello Health'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.5/10Brello Health's headline is $158 a month on a 3-month plan. Compare it with other programs on the same plan basis.
Effectiveness25%
7.6/10Brello Health offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
6.6/10Online intake and platform experience (consult included in the price); 2 platform features disclosed.
Trust & Safety15%
7.6/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.8/10Brello Health is available in 34 states plus DC.
Support10%
5.4/10Brello Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Brello Health review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 34 states plus DC
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $158–$197/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Brello Health
We walked Brello Health's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a plan on the site and pay at checkout. Prices are shown up front (Tirzepatide $166/mo, Semaglutide $133/mo as advertised, plus NAD+, Sermorelin, MICC, and GLP-1 bundles)
- 2After checkout, complete a short online intake form in your telehealth account (have a government-issued ID ready)
- 3A licensed healthcare provider reviews your information asynchronously, with no scheduled video visit
- 4If approved, compounded medication ships to your home in 3–5 business days; if you are not approved you receive a full refund
- 5Ongoing provider messaging plus included fitness/nutrition classes (Brello Rise) and a private community, all managed in the Brello app
- Prices are shown upfront on every product page. The homepage's 'Plans starting from $79/mo' is not a GLP-1 price; GLP-1 plans are advertised at $133/mo (semaglutide) and $166/mo (tirzepatide), billed every 11 weeks.
- Women-focused brand; states 80,000+ active members and a USA-based 503A partner pharmacy
- Full refund if a provider does not approve you; after a prescription is issued, a refund carries a $50 fee and must be requested within 24 hours
- You pay before the intake form ('No intake form required before you pay'), and there is no lab work or live video visit
- Every plan bundles virtual fitness/nutrition classes, a private community, and ongoing provider support
Brello Health customer support
- Phone
- 1-888-273-5561
GLP-1 medications Brello Health offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Brello Health offers
Beyond GLP-1s, Brello Health also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
then $158/mo
Save 16% right nowBrello advertises '$133/month', but the plan is billed $399 at checkout and then $399 every 11 weeks until canceled. Eleven weeks is about 2.5 calendar months, so the real cost is about $158 a month. $599 is a strikethrough price. There is no 1-month option.
then $197/mo
Save 16% right nowAdvertised as '$166/month'; billed $499 at checkout and then every 11 weeks, about $197 per calendar month. $749 is a strikethrough price. A 6-month plan is $894, renewing every 22 weeks (advertised as 'Averages $149/month'), shipped in two deliveries.
Ready to get started?
Plans and promotions change often, so check Brello Health's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide available
- Prices are shown on the site before you start
- Full refund if a provider doesn't approve you
- Virtual fitness and nutrition classes, a private community, and the Brello app included
- Ships in 3–5 business days if approved
Watch-outs
- 3-month minimum, and plans renew automatically every 11 weeks until canceled
- The advertised monthly price divides an 11-week charge by three, so the real calendar-month cost is higher
- You pay at checkout before completing the intake form
- After a prescription is issued, a refund costs a $50 fee and must be requested within 24 hours; nothing is refundable once dispensed
- Doesn't name its pharmacy or prescribers
Brello Health at a glance: a no-frills compounded GLP-1 platform
Brello Health is a straightforward telehealth wellness service built around one job: getting compounded semaglutide or tirzepatide into the hands of people who want to start a GLP-1 program without a lot of ceremony. There's no oral pill option, no brand-name Wegovy or Zepbound on the shelf, and no elaborate coaching apparatus. What you get is a provider health review, the medication if you're approved, the syringes and needles to inject it, and a library of virtual fitness and nutrition classes. If that bare-bones, medication-first setup is what you're after, Brello is a reasonable mainstream option. If you want hand-holding or a true month-to-month plan, it's a harder sell.
What Brello ships you
Brello deals only in compounded GLP-1s: pharmacy-mixed versions of semaglutide and tirzepatide, not the FDA-approved branded injectables. Understand that up front, because compounded drugs aren't reviewed by the FDA for safety or effectiveness the same way Wegovy, Ozempic, or Zepbound are. Brello does disclose the compounded nature of its medication on its own site, but it's on you to be comfortable with that trade-off. The upside of compounded is usually cost and availability; the downside is the lighter regulatory backing.
Each program includes the pieces you need to self-inject at home:
- A provider health review to determine if you're approved for treatment
- Your compounded medication (semaglutide or tirzepatide) if the provider signs off
- Syringes with needles included, so you're not sourcing supplies separately
- Access to virtual fitness and nutrition classes
One caveat on that last item: the classes are group-style virtual sessions, not one-on-one coaching. If you were hoping for a dedicated dietitian or a personal check-in cadence, set your expectations accordingly. Brello gives you educational content, not a personal coach.
The pricing: published, but billed every 11 weeks
Brello publishes its prices on every product page, but read them carefully. Semaglutide is advertised at $133 a month and tirzepatide at $166 a month, and both are 3-month plans: you're charged $399 (semaglutide) or $499 (tirzepatide) at checkout and again every 11 weeks until you cancel. Eleven weeks is about two and a half calendar months, so the calendar-month cost is closer to $158 and $197. A 6-month tirzepatide plan is $894, renewing every 22 weeks. There's no first-month teaser rate and no 1-month option, so the cost of trying it is several months of medication. For context, the typical compounded GLP-1 program lands around $179 a month. Because Brello asks for a multi-month minimum, this isn't a platform to 'dip a toe' into. Confirm the full amount charged at checkout and the renewal schedule, not just the advertised monthly figure, before you hand over a card. Shoppers who care most about avoiding a renewing plan can compare Rese Wellness, which sells a three-month first program and then lets you reorder one month at a time with no subscription, and it names its dispensing pharmacy. Halwel is another option: its 3-, 6- and 12-month plans are a single charge that doesn't renew on its own.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 129 programs that publish one.
Where you can (and can't) get it
Brello ships to 34 states plus Washington, D.C., which puts it in solidly mainstream coverage territory but not nationwide. The gaps include California, Washington, Nevada, Michigan, Indiana, West Virginia, North Carolina, South Carolina, Arkansas, Alabama, Tennessee, Hawaii, Massachusetts, Connecticut, New Jersey, and Maryland. That's a meaningful list. If you're in a big state like California, you're out of luck for now. Brello's own site says it's 'coming to more states soon,' so the map may widen, but don't count on access until it's live where you are. If you live in one of the excluded states, MaxLife serves patients nationwide and names its compounding pharmacies, though it was named in a February 2026 FDA warning letter.
Who Brello is right for, and who should skip it
Brello fits a specific kind of patient: someone who already knows they want a compounded GLP-1, is comfortable self-injecting, doesn't need intensive coaching, and lives in one of its covered states. For that person, the medication-plus-supplies-plus-classes bundle is clean and uncomplicated, and having both semaglutide and tirzepatide on the menu means you and your provider have a choice of molecule.
You should probably skip Brello if any of these apply:
- You want brand-name Wegovy, Ozempic, or Zepbound: Brello only offers compounded versions
- You want to try one month first: every plan has a 3-month minimum and renews every 11 weeks
- You want one-on-one coaching or a dedicated dietitian: the classes are group-style only
- You prefer an oral GLP-1: Brello is injection-only
- You live in California, Washington, New Jersey, or one of the other excluded states
Trust, safety, and what's missing
On the reassuring side, there are no FDA warning letters or enforcement actions on file against Brello. The platform is upfront that it dispenses compounded medication rather than dressing it up as branded product. A provider health review gates access to treatment, so you're not simply buying a drug off a shelf. On the cautious side, Brello doesn't disclose its compounding pharmacy partner or any accreditation details, and its advertised monthly prices understate the calendar-month cost. Medical gating paired with limited supply-chain transparency puts Brello in the 'fine for mainstream access, but check the details yourself' category rather than at the top of the class. You can read how we weigh these factors in our scoring methodology.
Bottom line
Brello Health does the core job competently. It covers 34 states plus D.C., offers both compounded semaglutide and tirzepatide, includes the injection supplies, and throws in virtual fitness and nutrition classes. It's an unfussy way to start a GLP-1 program if you're an informed, self-directed patient. The reasons to pause are equally clear: an advertised monthly price that understates the 11-week billing, a multi-month commitment, group-only classes, compounded-only medication, and undisclosed pharmacy accreditation. If you go in, do two things first: confirm the total charged at checkout and the renewal schedule, and make sure you're comfortable with compounded GLP-1s. Do that, and Brello is a serviceable mainstream pick. Skip those steps, and you're signing up blind.
The Bottom Line
Brello Health scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Brello Health?
From $158 a month on a 3-month plan. See current pricing and start your online intake.
Brello Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want a brand-name GLP-1 such as Wegovy or Zepbound, consider altRX.
- If you want built-in coaching and behavior-change support, consider Ro.
- If you live outside its coverage area and need nationwide access, consider CoreAge Rx.
Head-to-head
Compare Brello Health vs…
Brello Health scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
Brello Health vs Amazon One Medical
Amazon One Medical scores 8.5/10

Brello Health vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Brello Health review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Brello Health's current pricing
Plans from $158 a month on a 3-month plan. Start the online intake to check eligibility and today's price.